ImmunityBio (IBRX) Revenue Growth (5y) (2019 - 2026)
ImmunityBio (IBRX) Revenue Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | ImmunityBio | 7.60 Bn | 7.22 Bn | 43.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 216.59% |
| Dec 31, 2025 | 348.91% |
| Sep 30, 2025 | 192.01% |
| Jun 30, 2025 | 127.25% |
| Mar 31, 2025 | 151.24% |
| Dec 31, 2024 | 284.38% |
| Sep 30, 2024 | 247.79% |
| Jun 30, 2024 | 127.98% |
| Mar 31, 2024 | 51.57% |
| Dec 31, 2023 | 81.80% |
| Sep 30, 2023 | 21.48% |
| Jun 30, 2023 | 59.27% |
| Mar 31, 2023 | 135.22% |
| Dec 31, 2022 | 43.49% |
| Sep 30, 2022 | 71.30% |
| Jun 30, 2022 | 20.11% |
| Mar 31, 2022 | 4.94% |
| Dec 31, 2021 | 94.53% |
| Sep 30, 2021 | 40.63% |
| Jun 30, 2021 | 95.08% |